Vitamins and Minerals: Deficiencies to Monitor Under GLP-1
Vitamin and mineral deficiencies are an underestimated risk of GLP-1 agonist treatments. The appetite reduction induced by tirzepatide can lead to significant nutritional deficits that are essential to detect and prevent. Mechanisms of deficiencies under GLP-1 agonists Tirzepatide reduces caloric intake by 25 to 40% on average (SURMOUNT-1, NEJM … Read more